DOCSLIB.ORG

Effect of Omeprazole on the Secretion of Intrinsicfactor, Gastric Acid And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Effect of Omeprazole on the Secretion of Intrinsicfactor, Gastric Acid And Gut: first published as 10.1136/gut.26.6.594 on 1 June 1985. Downloaded from Gut, 1985, 26, 594-598 Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man E KITTANG, E AADLAND, AND H SCHJ0NSBY From Medical Department B, Aker University Hospital, Oslo, Norway. SUMMARY The effect of an intravenous infusion of omeprazole (0.35 mg/kg) and placebo on basal and stimulated (pentagastrin 1.0 ,ug/kg/h) secretion of gastric acid, intrinsic factor and pepsin was studied in 10 healthy male subjects. Omeprazole caused a marked inhibition of basal and stimulated acid output. The inhibition of pepsin output was less marked, but also significant. The output of intrinsic factor, however, showed no significant change. The results indicate that acid and intrinsic factor might have different secretory mechanisms within the parietal cell. Omeprazole (5-methoxy-2(((4-methoxy-3.5- Committee at Aker University Hospital, Oslo, dimethyl-2-pyrydinyl)-methyl)sulphinyl)-lH- Norway. benzimidazole), which is the most effective of the The gastric acid concentration was measured by substituted benzimidazoles, is a potent inhibitor of titration with 0-1 M NaOH to pH 7.4 using an acid secretion in isolated parietal cells,' isolated automatic titrator (Radiometer, Copenhagen, gastric glands,2 as both in animals3 and in man.45 Denmark). These drugs inhibit gastric acid secretion by a Aliquots of the gastric juice were depepsinised by mechanism different from antisecretagogues known adjusting the pH to 10 with 1M NaOH. After 30 http://gut.bmj.com/ so far, and studies have provided evidence that minutes the pH was adjusted to 7-0 with 1 M NaOH omeprazole inhibits the enzyme H+K+-ATP-ase,6 7 and stored at -20'C.'8 which is suggested to be the proton pump of the The intrinsic factor concentration was measured parietal cell.g-9 by the method of Gottlieb using intrinsic factor Intrinsic factorl as well as gastric acid is secreted antibody from patients with pernicious anaemia.19 by the parietal cell. Inhibitors of gastric acid The concentration of intrinsic factor in the gastric secretion such as histamine H2 receptor was in where 1 unit is the juice expressed U/ml, on September 25, 2021 by guest. Protected copyright. antagonists1-13 as well as atropine14 have been amount of intrinsic factor bound to 1 ng shown to reduce intrinsic factor secretion. Whether 57co-cyanocobalamin. The variation of duplicates or not omeprazole inhibits intrinsic factor secretion in the assay was found to be 1.78%±0-22% (mean is, however, not known. variation coefficient ±SD), and the between assay The present investigation was undertaken to variation coefficient 11 8%. The samples from the measure the effect of omeprazole on acid and omeprazole and the placebo experiments were intrinsic factor secretion. The effect of omeprazole analysed in the same batch. on pepsin secretion was also measured, since Pepsin concentration was measured by the previous studies have shown different results.15-17 method of Berstad20 using human haemoglobin as substrate, and samples with pH exceeding 6-0 were Methods excluded from the statistical analysis of the pepsin data. SUBJECTS The samples for pepsin and gastric acid Ten healthy male volunteers (mean age 26 years, determination were kept refrigerated until analysed. range 21-37 years) gave written informed consent to Aliquots containaing 61*3 mg omeprazole the study. The study was approved by the Ethical dissolved in 6-13 g polyethylenglycol (MW 400) were stored at -20°C until used. Before use omeprazole was diluted in 6-7 mmol/l NaHCO3 to Address for correspondence: Dr E Kittang, Medical Department B, Aker a final concentration of 4 mg/ml. 6 13 g Hospital, Oslo, Norway. polyethylenglycol diluted in 6-7 mmol/l NaHCO3 Received for publication 13 July 1984 was used as placebo. 594 Gut: first published as 10.1136/gut.26.6.594 on 1 June 1985. Downloaded from Omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man 595 PROCEDURE Pentagastrin (1Oglkg / h) The subjects fasted overnight. At 8 am a gastric tube - 120 was positioned with its tip in the distal part of the E 100 stomach under fluoroscopic control. The subjects E swallowed 200 ml of water, and the contents of the lI c 80 stomach were immediately aspirated. Omeprazole .2 -- 0-35 mg/kg or placebo was infused intravenously for 6 60 I, YI --r-j-1 five minutes in a double blind manner. One hour 0 -- Cc 40- T later an intravenous infusion of pentagastrin 0 -9 (Peptavlon, ICI, Pharmaceuticals Division, .' 20 Cheshire, UK) at a dose of 1-0 ,ug/kg/h was started I "I, and continued for 90 minutes. The gastric juice was 0 aspirated by continuous suction, and collected on ice ® 12 in 15 minute portions. Outputs of intrinsic factor and acid were calculated from measurements carried E10 out in aspirates obtained during the 60 minute basal Lfl period and the 90 minute period when pentagastrin E was infused. The pepsin data were calculated from E 6 the last 60 minutes with pentagastrin. Before and after termination of the experiments, PS- 4 blood and urine samples were taken for routine laboratory tests. (Blood: ESR, Hb, Hct, RBC, 2- WBC, differential count, thrombocytes, ASAT, ALAT, alkaline phosphatase, bilirubin, Na+, K+, Cl-, Ca2 , creatinine, bicarbonate. Urine: glucose, 15 minute periods protein, haemoglobin and microscopy). Omeprazole was well tolerated as no significant Fig. 1 Effect of iv omeprazole 0 35 mglkg on basal and changes were observed in laboratory values. Neither pentagastrin stimulated acid concentration (a), and acid output (b). Arrows indicate when omeprazole orplacebo http://gut.bmj.com/ were any side effects because of omeprazole seen or were infused. The results are shows as mean ± SEM. reported by the subjects. (o-0---o omeprazole, * * placebo). The results were presented as mean values and SEM. A paired Wilcoxon's ranked sum test was used for statistical analyses, and p values <0-05 were regarded as significant. PEPSIN SECRETION In the basal period omeprazole caused a marked rise Results in pH in gastric juice that exceeded 6 in several on September 25, 2021 by guest. Protected copyright. samples. As pepsin is irreversibly degraded at pH above 6,21 the pepsin data from the basal period ACID SECRETION were considered unreliable and was excluded from Both basal and pentagastrin stimulated gastric acid the statistical analyses. During pentagastrin output was significantly inhibited by omeprazole. stimulation mean pepsin output decreased from (Figure 1 b). The inhibition of basal acid output 125*3 mg±7*9 mg (placebo) to 79 6 mg±6-3 mg increased subsequently during the whole basal after omeprazole (p<0-01) whereas the mean pepsin period, indicating that the inhibition recorded was concentration increased from 413 mg/1±34 mg/l not maximal. The inhibition of stimulated acid (placebo) to 817 mg/1±189 mg/l after omeprazole output was 74-1%±5-2% (mean ±SEM; p<0-01), (p<001; Figure 3 a, b). and was because of a significant inhibition of both H+ concentrations (mean inhibition 39*0%±9 3%; Discussion Figure 1 a), and volumes of gastric juice (mean inhibition 59 1%±4*6%). The potent inhibitory effect of omeprazole on acid secretion was confirmed in the present study when INTRINSIC FACTOR SECRETION stimulating the secretion with a submaximal dose of Both basal and stimulated concentration of intrinsic pentagastrin (1-0 ,ug/kg/h; Fig 1 a,b). The output of factor was higher after omeprazole infusion than intrinsic factor was unchanged after omeprazole after placebo, whereas the output of intrinsic factor (Table, Fig 2 b). The concentration of intrinsic did not significantly change (Figure 2 a, b; Table). factor in the gastric juice increased, probably Gut: first published as 10.1136/gut.26.6.594 on 1 June 1985. Downloaded from 596 Kittang, Aadland, and Schjonsby Table Basal and pentagastrin (Pg) stimulated intrinsic factor concentration and intrinsic factor output after an intravenous infusion ofomeprazole andplacebo (Mean ±SEM) (ns = not significant) Intrinsicfactor concentration (Ulml) Cumulative intrinsic factor output Basal Pg Basal (U160 min) Pg (U190 min) Omeprazole 41-0±4-1 82-4±18-5 2479±540 13719±3172 Placebo 28-1±0-5 42-6±13-5 3239±836 16424±2051 p <0.01 <0-01 ns ns because of reduced volume secretion. Hence, the in the secretory membrane of the parietal cell,6 7 and results show that omeprazole, at a dose causing appears as such to be a peripherial step in the marked inhibition of acid secretion, has no effect on secretory mechanism of hydrochloric acid. The basal and pentagastrin stimulated intrinsic factor different effect of omeprazole on acid and intrinsic secretion. The effect of maximal doses of factor secretion therefore support the hypothesis omeprazole on intrinsic factor secretion is, however, that acid and intrinsic factor have separate secretory not known. mechanisms in the parietal cell. As the parietal cell is the site of both acid and Intrinsic factor is essential for normal absorption intrinsic factor production,10 the different effect of of vitamin B12. One might therefore expect that omeprazole on intrinsic factor and acid secretion is omeprazole treatment should be without effect on of interest. It is known that omeprazole interacts absorption of vitamin B12. Nevertheless it has been with the enzyme H+K+-ATP-ase, which is located proposed that achlorhydria or hypochlorhydria Pentogastrin (10,ug/kg/h I -a Pentagastrin (1 O0g/kg/h ) 12 r II http://gut.bmj.com/ n 160 'n 10 - 120 8- l 1 ,A-L---1~~~---l - ] .- j80 1 ? 61 I on September 25, 2021 by guest.
Load more

Recommended publications
  • Parietal Cell Hyperplasia Induced by Long-Term Administration of Antacids to Rats
    Gut: first published as 10.1136/gut.19.9.798 on 1 September 1978. Downloaded from Gut, 1978, 19, 798-801 Parietal cell hyperplasia induced by long-term administration of antacids to rats G. MAZZACCA1, F. CASCIONE, G. BUDILLON, L. D'AGOSTINO, L. CIMINO, AND C. FEMIANO From the Division of Gastroenterology, 2nd School ofMedicine, University ofNaples, and the Department ofPathology, Institute for Tumoral Diseases, Naples, Italv SUMMARY Suspension of magnesium and aluminum hydroxide (30-60 mEq/24 h) or a comparable volume of water was orally administered by gastric intubation to two groups of 20 male wistar rats each over 60 days. The antacid treatment led to a significant increase in the height (0-464 + 0-02 mm v. 0-318 ± 0 06) and in the volume (472 ± 32 mm3 v. 328 ± 45) of the fundic mucosa ofthe stomach, in the average count of parietal cells per unit area of the mucosa (32-37 ± 1 8 v. 22-3 + 1 6), and in the total parietal cell population of the stomach (53-6 + 3.5 x 106 v. 43-2 + 3.7 x 106). Furthermore fasting serum gastrin concentration was significantly higher in the antacid treated rats (81.2 + 7.4 pg/ml) than in control animals (56-9 ± 6-9 pg/ml). It is known that a feedback mechanism governs the The animals of group B received each time and by relationship between antral gastrin release and the same procedure a comparable volume of water. intraluminal gastric pH (Walsh et al., 1975). During the night each animal was housed in a Furthermore, gastrin exerts a trophic influence on separate cage and the antacid suspension was the the gastric mucosa with increase in the parietal cell only drinking fluid available to the rats of group A.
    [Show full text]
  • Overview of Gastrointestinal Function
    Overview of Gastrointestinal Function George N. DeMartino, Ph.D. Department of Physiology University of Texas Southwestern Medical Center Dallas, TX 75390 The gastrointestinal system Functions of the gastrointestinal system • Digestion • Absorption • Secretion • Motility • Immune surveillance and tolerance GI-OP-13 Histology of the GI tract Blood or Lumenal Serosal Side or Mucosal Side Structure of a villus Villus Lamina propria Movement of substances across the epithelial layer Tight junctions X Lumen Blood Apical membrane Basolateral membrane X X transcellular X X paracellular GI-OP-19 Histology of the GI tract Blood or Lumenal Serosal Side or Mucosal Side Motility in the gastrointestinal system Propulsion net movement by peristalsis Mixing for digestion and absorption Separation sphincters Storage decreased pressure GI-OP-42 Intercellular signaling in the gastrointestinal system • Neural • Hormonal • Paracrine GI-OP-10 Neural control of the GI system • Extrinsic nervous system autonomic central nervous system • Intrinsic (enteric) nervous system entirely with the GI system GI-OP-14 The extrinsic nervous system The intrinsic nervous system forms complete functional circuits Sensory neurons Interneurons Motor neurons (excitatory and inhibitory) Parasympathetic nerves regulate functions of the intrinsic nervous system Y Reflex control of gastrointestinal functions Vago-vagal Afferent reflex Salivary Glands Composition of Saliva O Proteins α−amylase lactoferrin lipase RNase lysozyme et al mucus O Electrolyte solution water Na+ , K + - HCO3
    [Show full text]
  • Expression of Cell Membrane Complement Regulatory Glycoproteins Along the Normal and Diseased Human Gastrointestinal Tract
    522 Gut 1998;42:522–529 Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract Gut: first published as 10.1136/gut.42.4.522 on 1 April 1998. Downloaded from A E Berstad, P Brandtzaeg Abstract tract. Indeed, activated complement has been Background/Aims—Uncontrolled comple- detected in lesions of inflammatory bowel ment activation may be of immunopatho- disease,2–4 coeliac disease,5 and recently also in logical importance in inflammatory Helicobacter pylori gastritis.6 diseases of the gastrointestinal tract. Ex- Certain complement activation products, pression of membrane bound factors that notably the C3b fragment and the C5b-7 com- regulate complement activation was there- plex, can on their own—that is, without associ- fore studied in situ. ated antibody—bind to any nearby cell Methods—Frozen tissue specimens were membrane.7 Therefore it is crucial that com- obtained from patients with Helicobacter plement activity is tightly regulated. Mam- pylori gastritis, coeliac disease, Crohn’s malian cells are protected from complement disease, or ulcerative colitis, and from induced damage by a family of cell membrane histologically normal controls. Sections complement regulatory glycoproteins that were examined by immunofluorescence downregulate activation of homologous com- with monoclonal antibodies to protectin plement on their cell surface.8 Protectin (CD59), decay accelerating factor (DAF), (CD59) is broadly distributed on cells of and membrane cofactor protein (MCP). haemopoietic and non-haemopoietic origin79; Results—Protectin and MCP were widely it inhibits the formation of terminal comple- expressed in normal and diseased mu- ment complex by preventing the binding of C9 cosae.
    [Show full text]
  • A Review of Normal Function and Role of Gastrin in Zollinger-Ellison
    When Gastrin Goes Awry: A Review of Normal Function and Role of Gastrin in Zollinger-Ellison Syndrome Leigha LaTourette1, Janel Cross2, Barbara Brabetz2 Department of Plant and Animal Science1, Department of Natural Sciences and Mathematics2 Introduction Gastrin: Normal Mode of Action Gastrin’s Role in Zollinger-Ellison Syndrome MEN 1 & ZES Gastrin is a digestive hormone that acts on the MEN1 is an inheritable disease that causes over neuroendocrine and parietal cells of the secretion of hormones via tumors on the gastrointestinal tract to ultimately secrete gastric endocrine glands throughout the body.4 Around a acid. Gastrin secretion begins even before food 30% of these tumors are found to be malignant. is consumed, as the mere anticipation of a meal ZES is commonly associated with the MEN1 due can lead to a series of events ending in the to the presence of tumors found in the stomach creation of the gastric acid needed to breakdown and small intestine.4 These gastrointestinal foods. Not only does Gastrin support the tumors caused by MEN 1 give the person a digestion of foods, but it also stimulates growth, higher likelihood of contracting ZES, as the secretion, blood flow, and acts as a defense probability of having pancreatic or duodenal mechanism against bacteria in the tumors is increased.4 gastrointestinal system. When the production of Gastrin becomes overt, major consequences like that of Zollinger Ellison Syndrome (ZES). ZES is an extremely rare disease occurring in people between the ages of 30-60.4 ZES is related to the uncontrolled secretion of gastrin due to the presence of certain pancreatic or duodenal tumors.
    [Show full text]
  • Gastric Fundic Gland Polyps: Can Histology Be Useful to Predict Proton Pump Inhibitors Use?
    AG-2018-75 ORIGINAL ARTICLE dx.doi.org/10.1590/S0004-2803.201800000-82 Gastric fundic gland polyps: can histology be useful to predict proton pump inhibitors use? Hugo Leite de Farias BRITO, Cynthia BARROS, Marcelle Vieira FREIRE, Miraldo Nascimento da SILVA FILHO and Tereza Virgínia NASCIMENTO Received 17/6/2018 Accepted 15/10/2018 ABSTRACT – Background – Fundic gland polyps allegedly increased in frequency in recent decades, and had attracted great attention due to possible association with prolonged proton pump inhibitor therapy. Prolonged use of this drug could cause parietal cell hyperplasia, obstruction of glandular lumen and cystic dilation of the gland. Objective – This study aims to analyze clinical and pathological features of fundic gland polyps in patients with and without proton pump inhibitor therapy in a selected population from Brazil. Methods – It was selected a sample of 101 Brazilian patients (78 females and 23 males), from a five years retrospective search of the files from a private pathology laboratory. The patients had an average age of 57 years and we included patients with a histological diagnosis of fundic gland polyp. The clinical data were obtained from their files and all histological slides were reviewed and examined with hematoxylin and eosin (HE) and Giemsa. Results – Information about the use or non-use of proton pump inhibitors (PPI) was obtained in 84 patient files. In 17 cases we could not determine if PPI were used or not. Among those in which the information was available, a positive history of anti-acid therapy was observed in 63 (75.0%) patients. Parietal cell hypertrophy/hyperplasia and parietal cell protrusions were detected in most slides.
    [Show full text]
  • Molecular Characterization of Gastric Epithelial Cells Using Flow Cytometry
    International Journal of Molecular Sciences Article Molecular Characterization of Gastric Epithelial Cells Using Flow Cytometry Kevin A. Bockerstett, Chun Fung Wong, Sherri Koehm ID , Eric L. Ford and Richard J. DiPaolo * Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA; [email protected] (K.A.B.); [email protected] (C.F.W.); [email protected] (S.K.); [email protected] (E.L.F.) * Correspondence: [email protected]; Tel.: +1-(314)-977-8860; Fax: +1-(314)-977-8717 Received: 24 March 2018; Accepted: 4 April 2018; Published: 6 April 2018 Abstract: The ability to analyze individual epithelial cells in the gastric mucosa would provide important insight into gastric disease, including chronic gastritis and progression to gastric cancer. However, the successful isolation of viable gastric epithelial cells (parietal cells, neck cells, chief cells, and foveolar cells) from gastric glands has been limited due to difficulties in tissue processing. Furthermore, analysis and interpretation of gastric epithelial cell flow cytometry data has been difficult due to the varying sizes and light scatter properties of the different epithelial cells, high levels of autofluorescence, and poor cell viability. These studies were designed to develop a reliable method for isolating viable single cells from the corpus of stomachs and to optimize analyses examining epithelial cells from healthy and diseased stomach tissue by flow cytometry. We performed a two stage enzymatic digestion in which collagenase released individual gastric glands from the stromal tissue of the corpus, followed by a Dispase II digestion that dispersed these glands into greater than 1 × 106 viable single cells per gastric corpus.
    [Show full text]
  • Physiology of the Stomach and Regulation of Gastric Secretions
    LECTURE III: Physiology of the Stomach and Regulation of Gastric Secretions EDITING FILE IMPORTANT MALE SLIDES EXTRA FEMALE SLIDES LECTURER’S NOTES 1 PHYSIOLOGY OF THE STOMACH AND REGULATION OF GASTRIC SECRETIONS Lecture Three OBJECTIVES •Functions of stomach. •Gastric secretion. •Mechanism of HCl formation. •Gastric digestive enzymes. •Neural & hormonal control of gastric secretion. •Phases of gastric secretion. •Motor functions of the stomach. •Stomach Emptying. Functional Anatomy of the Stomach: Orad (Reservoir) fundus and upper two orad thirds of the body physiologically Caudad (Antral Pump) lower third of the body plus antrum Caudad Figure 3-1 stomach fundus anatomical body antrum Figure 3-2 ● Gastric mucosa is formed of columnar epithelium that is folded into “pits”. ● The pits are the opening of gastric glands. ● There are several types of gastric glands in the stomach and are distributed differentially in the stomach. Figure 3-3 2 PHYSIOLOGY OF THE STOMACH AND REGULATION OF GASTRIC SECRETIONS Lecture Three Types of Gastric Glands: Mucus secreting glands oxyntic(parietal)glands Pyloric glands (cardiac glands) (most abundant glands) Mucus neck cells Types of cells - Peptic (Chief) cells Many G cells Parietal cells (Oxyntic cells) HCl Gastrin Mucus Pepsinogen secrete Mucus HCO3 IF Mucus Body & fundus Antrum Found in Cardia (above the notch) (below the notch) Proximal 80% of stomach Distal 20% of stomach Structure of a Gastric Oxyntic Gland: ★ HCl is secreted across the parietal cell microvillar membrane and flows out of the intracellular canaliculi into the oxyntic gland lumen. ★ The surface mucous cells line the entire surface of the gastric mucosa and the openings of the cardiac, pyloric, and oxyntic glands.
    [Show full text]
  • Gastrin Receptor (G Protein-Coupled Receptor/Cholecystokinin/Gastric Mucoa) ALAN S
    Proc. Nati. Acad. Sci. USA Vol. 89, pp. 3605-3609, April 1992 Biochemistry Expression cloning and characterization of the canine parietal cell gastrin receptor (G protein-coupled receptor/cholecystokinin/gastric mucoa) ALAN S. KOPIN*t, YOUNG-MEE LEE*, EDWARD W. MCBRIDE*, LAURENCE J. MILLER*, MING Lu§, HERBERT Y. LIN¶, LEE F. KOLAKOWSKI, JR. 11, AND MARTIN BEINBORN** *Division of Gastroenterology and GRASP Digestive Disease Center, New England Medical Center, Tufts University School of Medicine, Boston, MA 02111; tGastroenterology Research Unit, Mayo Graduate School of Medicine, Rochester, MN 55905; §Department of Cell Biology, Baylor College of Medicine, Houston, TX 77035; 1Whitehead Institute for Biomedical Research, Cambridge, MA 02142; "1Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114; and **Department of General Pharmacology, Medical School, Hannover, Federal Republic of Germany Communicated by Harvey F. Lodish, January 21, 1992 ABSTRACT Gastrin is an important stimulant of acid tain brain nuclei, has a 1000-fold higher affinity for CCK than secretion by gastric parietal cells and is structurally related to for gastrin. CCK-B/gastrin receptors are found in the brain the peptide hormone cholecystokinin (CCK). The pharmaco- (CCK-B), on smooth muscle cells, and on parietal cells logic properties of the parietal cell gastrin receptor are very (gastrin receptors). Agonist-binding studies on brain mem- similar to the predominant CCK receptor in the brain, CCK-B. branes and parietal cells show a 6- to 10-fold and a 1- to 2-fold Neither the gastrin nor the CCK-B receptor have been cloned higher affinity for CCK than for gastrin, respectively (9). thus far, making it difficult to resolve whether these two These small differences in agonist binding have created receptors are distinct.
    [Show full text]
  • Stomach Tumors Benign Tumors Fundic Gland Polyps Benign
    Last updated: 6/11/2020 Prepared by Kurt Schaberg Stomach Tumors Benign Tumors Fundic Gland Polyps Benign. Most common stomach polyp. Hyperplastic expansion of deep oxyntic mucosa with cystically dilated oxyntic glands and foveolar hypoplasia. Parietal cell hyperplasia Usually asymptomatic and incidental. Associated with PPI use Can have CTNNB1 (β-catenin) mutations If numerous (esp. >20) in a young patient, consider a polyposis syndrome, such as FAP. Hyperplastic Polyps Benign. Second most common gastric polyp Elongated, tortuous, hyperplastic foveolar epithelium Cystically dilated glands Inflammatory changes and edema Often eroded at surface. Small, haphazardly distributed smooth muscle Hyperproliferative response to tissue injury. Usually arise in setting of long-standing gastritis Precursor lesion = polypoid foveolar hyperplasia May be hard to differentiate from hamartomatous polyps (e.g., Cronkhite-Canada syndrome) Pyloric Gland adenoma Polypoid proliferation of pyloric-type gastric glands (cuboidal to columnar cells with foamy, ground- glass cytoplasm) and no well-formed apical mucin cap. Often dilated glands. Basal round nuclei. Usually older individuals with atrophic/metaplastic autoimmune gastritis and/or H. pylori Sometimes syndromic (e.g., FAP, GAPPs, etc…) Activating GNAS and/or KRAS mutations and inactivating APC mutations. Can develop high-grade dysplasia → carcinoma Stain with MUC6 Dysplasia Low-grade foveolar-type dysplasia Neoplastic change of gastric epithelium without stromal invasion. Can be gastric/foveolar or intestinal-type (or mixed): Intestinal-type dysplasia: looks like a colonic adenoma with tall columnar cells with hyperchromatic nuclei Gastric/Foveolar-type dysplasia has tubulovillous or serrated fronds lined by cuboidal to columnar cells resembling gastric foveolar cells. Nuclei are round to oval. There is apical neutral mucin.
    [Show full text]
  • CBI 203 Mini Physiology
    Introductory Human Physiology ©copyright Emma Jakoi DIGESTIVE SYSTEM -1 Emma Jakoi. Ph.D. LEARNING OBJECTIVES 1. Describe the functional anatomy and role of the digestive system. 2. Describe the production of gastric acid in the stomach. 3. Describe the time course of acid secretion in the fed and fasted states OVERVIEW The digestive system provides nutrients, water, and electrolytes to the cells of the body from the external environment. Food enters the oral cavity and is propelled by muscular contractions through the gastrointestinal (GI) tract moving towards the anus. At various points along the GI tract, acid, digestive enzymes, and buffers are added to facilitate the breakdown of complex foods (such as steak and rice) into simple molecules (such as amino acids, glucose, and fatty acids). These products are then absorbed into the body and delivered to the liver. The various secretions of the GI tract (enzymes, mucus, and water) sum to about 7 liters. This fluid is reabsorbed to prevent dehydration. Unabsorbed nutrients and waste products are eliminated from the body as feces (100 mL – 500mL per day). ANATOMY The digestive system includes the gastrointestinal tract and accessory organs (Fig 1). The gastrointestinal tract is a muscular tube about 5 meters in length. It includes the mouth, pharynx, esophagus, stomach, small intestine and large intestine (colon). Voluntary control occurs at the top and bottom of the tube. Movement through the rest of the gastrointestinal tract is involuntary and unidirectional from mouth to anus. Salivary glands Liver Pancreas Gall bladder Figure 1. Functional regions of the gastrointestinal tract. X marks the sphincters under voluntary control.
    [Show full text]
  • Gastric Secretions
    NASPGHAN Physiology Series Gastric Secretions Christine Waasdorp Hurtado, MD, MSCS, FAAP University of Colorado School of Medicine Children’s Hospital Colorado [email protected] Reviewed by Brent Polk, MD and Thomas Sferra, MD H. Pylori (Slides 5-8) H. pylori, flagellated organism, colonize the gastric epithelium of 50% of the world’s population. Complications of infection include gastritis, peptic ulcers, mucosa-associated lymphoid tissue lymphoma (MALT), and gastric cancer. The flagella promote motility in the mucus layer. The organism binds to antigens on gastric epithelial cells, thus preventing mechanical clearance. The organism hydrolyzes urea locally resulting in an increase in gastric pH. Acute infections cause hypochlorhydria due to inhibition of acid secretion. There are three mechanisms involved in acid inhibition; pro-inflammatory cytokine interleukin-1β, suppression of proton pump α-subunit promoter activity and interference in trafficking via tubulovessicles. In chronic infection the stomach may have hypochlorhydria or hyperchlorhydria depending on the severity and location of involvement. Most patients have a pangastritispan gastritis and produce less than normal acid. Twelve percent of infected individuals have an antral dominant infection with inflammation. In antral dominant there is increased acid secretion due to reduced amounts of Somatostatin and increased gastrin. These patients are predisposed to develop a duodenal ulcer. Organism eradication results in normalization of acid, gastrin and Somatostatin. Transmission is by person-to-person contact. Infections are very rare in infants, even if the mother is infected. Re-infection rates are low, but recrudescence (same strain in <12 months) is common. Diagnosis is by one of several tests. Serum H.
    [Show full text]
  • Gastric Acid Secretion in Cholecystokinin-1 Receptor, -2 Receptor, and -1, -2 Receptor Gene Knockout Mice
    J Physiol Sci (2009) 59:23–29 DOI 10.1007/s12576-008-0001-y ORIGINAL PAPER Gastric acid secretion in cholecystokinin-1 receptor, -2 receptor, and -1, -2 receptor gene knockout mice Setsuko Kanai Æ Hiroko Hosoya Æ Saeko Akimoto Æ Minoru Ohta Æ Toshimitsu Matsui Æ Soichi Takiguchi Æ Akihiro Funakoshi Æ Kyoko Miyasaka Received: 6 June 2007 / Accepted: 26 September 2008 / Published online: 30 November 2008 Ó The Physiological Society of Japan and Springer 2008 Abstract Gastrin is important for stimulating acid secre- was impaired in mice without CCK-2R. The interaction of tion as well as differentiating gastric mucosal cells via histamine and carbachol was conserved in all genotypes. In cholecystokinin-2 receptors (CCK-2Rs). In turn, CCK acts conclusion, CCK-2R is necessary to respond to carbachol as preferably via CCK-1R to release somatostatin, and well as to produce the maximal acid secretion, while the role somatostatin has been postulated to exhibit a tonic inhibition of CCK-1R in acid secretion is less important. of gastrin bioactivity. The present study was designed to examine the hypothesis that CCK-1R and 2R may act in Keywords Acetylcholine Á CCK Á Knockout Á Mice opposite directions in gastric acid secretion. Having gener- ated CCK-1R(-/-), 2R(-/-), and 1R(-/-)2R(-/-) mice, we examined the regulation of gastric acid secretion in four Introduction genotypes including wild-type mice. Parietal cells possess histamine receptors, muscarinic receptors, and CCK-2Rs. Gastric acid secretion is regulated in a complex manner by Since histamine increases cAMP and carbachol increases neurocrine, endocrine, and paracrine signals.
    [Show full text]